1. What Happened? Miwon’s H1 2025 Performance Review

Miwon Specialty Chemical released its H1 2025 report on August 14th, revealing a decline in sales and profits. Revenue dropped by 46.5% year-on-year to KRW 272.671 billion, with operating and net profits also decreasing by 36.7% and 48.1% respectively. Discrepancies with preliminary figures necessitate further verification. Despite the negative performance, the debt-to-equity ratio improved to 24.18%, indicating strengthened financial health.

2. Why the Decline? Analyzing the Factors and Market Conditions

The decline can be attributed to a combination of market conditions and external factors, including the ongoing US anti-dumping investigation. While the demand for eco-friendly products offers growth potential, foreign exchange volatility and fluctuations in raw material prices have impacted profitability. The US anti-dumping investigation remains a significant variable that could affect future performance.

3. What’s Next? Outlook and Investment Strategies for Miwon

Miwon holds long-term growth potential as a leader in the energy curing market. However, the company faces short-term uncertainties stemming from the US anti-dumping investigation and currency fluctuations. A conservative approach is recommended for short-term investments. For mid-to-long-term investments, decisions should be made after considering factors like the company’s strategy for recovery, its response to the anti-dumping investigation, and its foreign exchange risk management.

4. Investor Action Plan: Key Checkpoints

  • Short-term Investment: Cautious approach, observation recommended.
  • Mid-to-Long-term Investment: Maintain a neutral to positive outlook, make investment decisions after reviewing key information.
  • Risk Management: Utilize a diversified investment strategy.